Patents by Inventor Mary Ellen Warchal-Windham

Mary Ellen Warchal-Windham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11268925
    Abstract: Devices and methods for determining one or more analyte concentrations in a sample, determining a sample type, and/or accounting for interference species in a sample are disclosed that include intertwining a first input signal, via a first electrode having a reagent, with a second input signal, via a second electrode lacking a reagent, by applying to the sample the first input signal having at least two excitations and a relaxation, and applying to the sample the second input signal having at least two excitations and a relaxation, such that the excitations of the first input signal are nonconcurrent with the excitations of the second input signal. The method further includes measuring a first output signal responsive to the first input signal and a second output signal responsive to the second input signal.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: March 8, 2022
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Huan-Ping Wu, Mary Ellen Warchal-Windham, Bern Everett Harrison, Nicole D. Ellis
  • Patent number: 11180790
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: November 23, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Publication number: 20200270668
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Application
    Filed: May 13, 2020
    Publication date: August 27, 2020
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Patent number: 10696998
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: June 30, 2020
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Publication number: 20190293594
    Abstract: Devices and methods for determining one or more analyte concentrations in a sample, determining a sample type, and/or accounting for interference species in a sample are disclosed that include intertwining a first input signal, via a first electrode having a reagent, with a second input signal, via a second electrode lacking a reagent, by applying to the sample the first input signal having at least two excitations and a relaxation, and applying to the sample the second input signal having at least two excitations and a relaxation, such that the excitations of the first input signal are nonconcurrent with the excitations of the second input signal. The method further includes measuring a first output signal responsive to the first input signal and a second output signal responsive to the second input signal.
    Type: Application
    Filed: July 7, 2017
    Publication date: September 26, 2019
    Inventors: Huan-Ping Wu, Mary Ellen Warchal-Windham, Bern Everett Harrison, Nicole D. Ellis
  • Publication number: 20170349929
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Application
    Filed: August 21, 2017
    Publication date: December 7, 2017
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Patent number: 9664638
    Abstract: A biosensor system for determining the concentration of an analyte in a sample includes a plurality of test sensors, and includes a container including a desiccant and the plurality of test sensors, sealed in the container. When the container is stored for two weeks at a temperature of 50° C., and each test sensor is subsequently removed from the container, connected through the at least two conductors to a measurement device and then contacted with one of a plurality of samples including an analyte, where the plurality of samples has analyte concentrations that span the range of 50 mg/dL-600 mg/dL, and the analyte concentration in each sample is determined by the test sensor and the measuring device, the bias of each determined analyte concentration may be within ±10 mg/dL or ±10%, and the coefficient of variation of the determined analyte concentrations may be at most 2.5%.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: May 30, 2017
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Amy H. Chu, Mary Ellen Warchal-Windham
  • Publication number: 20160084790
    Abstract: A biosensor system for determining the concentration of an analyte in a sample includes a plurality of test sensors, and includes a container including a desiccant and the plurality of test sensors, sealed in the container. When the container is stored for two weeks at a temperature of 50° C., and each test sensor is subsequently removed from the container, connected through the at least two conductors to a measurement device and then contacted with one of a plurality of samples including an analyte, where the plurality of samples has analyte concentrations that span the range of 50 mg/dL-600 mg/dL, and the analyte concentration in each sample is determined by the test sensor and the measuring device, the bias of each determined analyte concentration may be within ±10 mg/dL or ±10%, and the coefficient of variation of the determined analyte concentrations may be at most 2.5%.
    Type: Application
    Filed: December 3, 2015
    Publication date: March 24, 2016
    Inventors: Amy H. Chu, Mary Ellen Warchal-Windham
  • Patent number: 9233788
    Abstract: A biosensor system for determining the concentration of an analyte in a sample includes a plurality of test sensors, and includes a container including a desiccant and the plurality of test sensors, sealed in the container. When the container is stored for two weeks at a temperature of 50° C., and each test sensor is subsequently removed from the container, connected through the at least two conductors to a measurement device and then contacted with one of a plurality of samples including an analyte, where the plurality of samples has analyte concentrations that span the range of 50 mg/dL-600 mg/dL, and the analyte concentration in each sample is determined by the test sensor and the measuring device, the bias of each determined analyte concentration may be within ±10 mg/dL or ±10%, and the coefficient of variation of the determined analyte concentrations may be at most 2.5%.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: January 12, 2016
    Assignee: Bayer HealthCare LLC
    Inventors: Amy H. Chu, Mary Ellen Warchal-Windham
  • Publication number: 20130186755
    Abstract: A biosensor system for determining the concentration of an analyte in a sample includes a plurality of test sensors, and includes a container including a desiccant and the plurality of test sensors, sealed in the container. When the container is stored for two weeks at a temperature of 50° C., and each test sensor is subsequently removed from the container, connected through the at least two conductors to a measurement device and then contacted with one of a plurality of samples including an analyte, where the plurality of samples has analyte concentrations that span the range of 50 mg/dL-600 mg/dL, and the analyte concentration in each sample is determined by the test sensor and the measuring device, the bias of each determined analyte concentration may be within ±10 mg/dL or ±10%, and the coefficient of variation of the determined analyte concentrations may be at most 2.5%.
    Type: Application
    Filed: July 19, 2012
    Publication date: July 25, 2013
    Applicant: BAYER HEALTHCARE LLC - DIABETES CARE
    Inventors: Amy H. Chu, Mary Ellen Warchal-Windham
  • Patent number: 8184273
    Abstract: A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: May 22, 2012
    Assignee: Bayer Healthcare LLC
    Inventors: Andrew J. Dosmann, Christine D. Nelson, Mary Ellen Warchal-Windham
  • Publication number: 20110102768
    Abstract: A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence.
    Type: Application
    Filed: January 10, 2011
    Publication date: May 5, 2011
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Andrew J. Dosmann, Christine D. Nelson, Mary Ellen Warchal-Windham
  • Patent number: 7867728
    Abstract: The glucose content of blood can be determined by contacting a blood sample with a test strip containing a glucose dehydrogenase dependent on PQQ (or derivatives or isomers) thereof as a co-factor, a tetrazolium salt indicator, but in the absence of a mediator.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: January 11, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: Karen L. Marfurt, Mary Ellen Warchal-Windham
  • Patent number: 7869009
    Abstract: A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: January 11, 2011
    Assignee: Bayer Healthcare LLC
    Inventors: Andrew J. Dosmann, Christine D. Nelson, Mary Ellen Warchal-Windham
  • Publication number: 20100279326
    Abstract: A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence.
    Type: Application
    Filed: July 12, 2010
    Publication date: November 4, 2010
    Applicant: Bayer HealthCare LLC
    Inventors: Andrew J. Dosmann, Christine D. Nelson, Mary Ellen Warchal-Windham
  • Patent number: 7787109
    Abstract: A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence.
    Type: Grant
    Filed: December 12, 2005
    Date of Patent: August 31, 2010
    Assignee: Bayer Healthcare LLC
    Inventors: Andrew J. Dosmann, Christine D. Nelson, Mary Ellen Warchal-Windham
  • Publication number: 20090145775
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Application
    Filed: December 10, 2008
    Publication date: June 11, 2009
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Publication number: 20080248581
    Abstract: A device and method for determining a correction factor for correcting the blood glucose assay bias based on sample hematocrit interference in a testing device using the blood hemoglobin concentration. The hemoglobin assay and the glucose assay may be performed using a single combination monitoring device.
    Type: Application
    Filed: March 26, 2008
    Publication date: October 9, 2008
    Inventors: Amy H. Chu, Mary Ellen Warchal-Windham
  • Publication number: 20080198360
    Abstract: A total transmission spectroscopy system for use in determining the analyte concentration in a fluid sample comprises a sample cell receiving area, a light source, a collimating lens, a first lens, a second lens, and a detector. The sample cell receiving area is adapted to receive a sample to be analyzed. The sample cell receiving area is constructed of a substantially optically clear material. The collimating lens is adapted to receive light from the light source and adapted to illuminate the sample cell receiving area with a substantially collimated beam of light. The first lens is adapted to receive regular and scattered light transmitted through the sample at a first angle of divergence. The first lens receives light having a first angle of acceptance. The first lens outputs light having a second angle of divergence. The second angle of divergence is less than the first angle of divergence.
    Type: Application
    Filed: December 12, 2005
    Publication date: August 21, 2008
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Andrew J. Dosmann, Christine D. Nelson, Mary Ellen Warchal-Windham
  • Patent number: 7163616
    Abstract: Reagents for detecting an analyte are described. A reagent comprises (a) an enzyme selected from the group consisting of a flavoprotein, a quinoprotein, and a combination thereof; and (b) a mediator selected from the group consisting of a phenothiazine, a phenoxazine, and a combination thereof. In addition, reagents having good stability to radiation sterilization are described. Electrochemical sensors and sampling devices comprising such reagents, methods of producing a sterilized device including such reagents, and methods for detecting an analyte which utilize such reagents are described as well.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: January 16, 2007
    Assignee: Bayer Corporation
    Inventors: Mark S. Vreeke, Mary Ellen Warchal-Windham, Christina Blaschke, Barbara J. Mikel, Howard A. Cooper